Author:
Fu Fangqiu,Zhang Yang,Chen Haiquan
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Pless M, Stupp R, Ris HB, et al. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet. 2015;386(9998):1049–56.
2. van Meerbeeck JP, Kramer GW, Van Schil PE, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst. 2007;99(6):442–50.
3. Ettinger DS, Wood DE, Aisner DL, et al. Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(5):497–530.
4. Postmus PE, Kerr KM, Oudkerk M, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl 4):41–421.
5. Fu F, Sun W, Bai J, et al. Long-term outcomes of selected patients with IIIA-N2 non-small cell lung cancer receiving upfront surgical resectionTreating lung cancer: defining surgical curative time window. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14072-4.